A new cancer vaccine is being created to analyse how pre-cancerous cells develop to target the disease before it takes hold. Pharmaceutical giant GSK and the University of Oxford have partnered to develop the Cancer Immuno-Prevention Programme to create a single jab or multiple vaccines. The vaccine will specifically target the pre-cancerous cells.